- Home
- BOLT vs ASPS Comparison
BOLT vs ASPS Comparison
Compare BOLT & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- ASPS
- Stock Information
- Founded
- BOLT 2015
- ASPS 1999
- Country
- BOLT United States
- ASPS Luxembourg
- Employees
- BOLT N/A
- ASPS N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- BOLT Health Care
- ASPS Consumer Discretionary
- Exchange
- BOLT Nasdaq
- ASPS Nasdaq
- Market Cap
- BOLT 22.6M
- ASPS 22.8M
- IPO Year
- BOLT 2021
- ASPS N/A
- Fundamental
- Price
- BOLT $0.44
- ASPS $0.84
- Analyst Decision
- BOLT Hold
- ASPS
- Analyst Count
- BOLT 5
- ASPS 0
- Target Price
- BOLT $1.25
- ASPS N/A
- AVG Volume (30 Days)
- BOLT 105.0K
- ASPS 169.6K
- Earning Date
- BOLT 03-20-2025
- ASPS 04-24-2025
- Dividend Yield
- BOLT N/A
- ASPS N/A
- EPS Growth
- BOLT N/A
- ASPS N/A
- EPS
- BOLT N/A
- ASPS N/A
- Revenue
- BOLT $9,779,000.00
- ASPS $153,278,000.00
- Revenue This Year
- BOLT $9.87
- ASPS $14.04
- Revenue Next Year
- BOLT N/A
- ASPS $33.86
- P/E Ratio
- BOLT N/A
- ASPS N/A
- Revenue Growth
- BOLT 35.86
- ASPS 5.19
- 52 Week Low
- BOLT $0.42
- ASPS $0.43
- 52 Week High
- BOLT $1.56
- ASPS $3.11
- Technical
- Relative Strength Index (RSI)
- BOLT 36.26
- ASPS 55.77
- Support Level
- BOLT $0.42
- ASPS $0.65
- Resistance Level
- BOLT $0.48
- ASPS $0.75
- Average True Range (ATR)
- BOLT 0.03
- ASPS 0.08
- MACD
- BOLT -0.00
- ASPS -0.00
- Stochastic Oscillator
- BOLT 16.00
- ASPS 99.95
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.